PYXIS ONCOLOGY INC. - COMMON STOCK

Pyxis Oncology to Participate in the Virtual 2023 SVB Securities Global Biopharma Conference

13 фев 2023 08:00:00 Источник Nasdaq GlobeNewswire

Pyxis Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

23 дек 2022 16:45:00 Источник Nasdaq GlobeNewswire

Pyxis Oncology Announces FDA Clearance of Two IND Applications

01 дек 2022 06:45:00 Источник Nasdaq GlobeNewswire

Pyxis Oncology Reports Financial Results for the Quarter Ended September 30, 2022 and Provides Corporate Update

01 ноя 2022 06:30:00 Источник Nasdaq GlobeNewswire

Pyxis Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

30 сен 2022 17:00:00 Источник Nasdaq GlobeNewswire

Pyxis Oncology Reports Financial Results for the Second Quarter Ended June 30, 2022 and Provides Pipeline Update

15 авг 2022 07:00:01 Источник Nasdaq GlobeNewswire

Pyxis Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

12 июл 2022 06:45:00 Источник Nasdaq GlobeNewswire

Pyxis Oncology to Present at H.C. Wainwright Preclinical Cancer Drug Discovery Conference

28 июн 2022 06:35:00 Источник Nasdaq GlobeNewswire

Pyxis Oncology Announces Presentations at Upcoming Investor Conferences

19 май 2022 06:35:00 Источник Nasdaq GlobeNewswire

Pyxis Oncology Reports Financial Results for the Quarter Ended March 31, 2022 and Provides Business Update

13 май 2022 08:03:06 Источник Nasdaq GlobeNewswire

Pyxis Oncology to Participate in Fireside Chat at BofA Securities 2022 Healthcare Conference

27 апр 2022 06:35:00 Источник Nasdaq GlobeNewswire

Pyxis Oncology Announces Leadership Changes

13 апр 2022 06:35:00 Источник Nasdaq GlobeNewswire

Pyxis Oncology Announces Preclinical Data on Anti-Siglec-15 BSI-060T (PYX-106) Presented by Biosion, Inc. at the 2022 American Association for Cancer Research (AACR) Annual Meeting

08 апр 2022 13:05:00 Источник Nasdaq GlobeNewswire

Pyxis Oncology Provides Corporate and Financial Update

29 мар 2022 06:35:00 Источник Nasdaq GlobeNewswire

Pyxis Oncology to Host Corporate Update Conference Call and Webcast on March 29, 2022

22 мар 2022 06:35:00 Источник Nasdaq GlobeNewswire

Pyxis to be Added to Russell 2000® Index

15 дек 2021 08:00:01 Источник Nasdaq GlobeNewswire

Pyxis Oncology Appoints Martina Molsbergen as Interim Chief Business Officer

09 дек 2021 08:30:00 Источник Nasdaq GlobeNewswire

Pyxis Reports Financial Results for the Third Quarter of 2021 and Provides Business Update

15 ноя 2021 07:15:00 Источник Nasdaq GlobeNewswire

Pyxis Oncology to Present at the Jefferies London Healthcare Conference

10 ноя 2021 08:00:02 Источник Nasdaq GlobeNewswire

Pyxis Announces Pricing of Upsized Initial Public Offering

07 окт 2021 22:24:50 Источник Nasdaq GlobeNewswire